Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL810P is a pseudogene that encodes a nonfunctional, truncated homolog of the 7SL RNA, which is the RNA component of the signal recognition particle (SRP). SRP is an essential ribonucleoprotein that mediates the co-translational targeting of secretory proteins to the endoplasmic reticulum in eukaryotic cells[1][3][4][5]. However, the RN7SL810P pseudogene does not produce a functional RNA and is not expressed or involved in cellular pathways; it is part of a large number of dispersed, nonfunctional SRP RNA-derived sequences throughout the human genome[1][3][4][5]. Key context: - The functional gene family, such as RN7SL1, encodes the actual 7SL RNA used in the signal recognition particle complex[6]. - The vast majority of SRP RNA-related sequences in the human genome are pseudogenes, reverse-transcribed and integrated into DNA, and do not code for functional products[3][4][5]. - Such pseudogenes are generally considered "molecular fossils" without biological activity or roles as drug targets, biomarkers, or therapeutic receptors[3][4][5]. - There are no known drugs, mechanisms of action, or disease associations for this pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 810, pseudogene (RN7SL810P).